Ignite Creation Date:
2025-12-24 @ 7:34 PM
Ignite Modification Date:
2025-12-28 @ 7:30 PM
Study NCT ID:
NCT01915303
Status:
TERMINATED
Last Update Posted:
2020-09-18
First Post:
2013-06-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-03-06
Start Date Type:
ACTUAL
Primary Completion Date:
2016-09-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-09-04
Completion Date Type:
ACTUAL
First Submit Date:
2013-06-10
First Submit QC Date:
None
Study First Post Date:
2013-08-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-08-28
Results First Submit QC Date:
None
Results First Post Date:
2020-09-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-08-28
Last Update Post Date:
2020-09-18
Last Update Post Date Type:
ACTUAL